William McConnell

Bill McConnell has led The Deal 's coverage of the nation's capital since becoming Washington bureau chief in 2005. His reporting has covered a range of issues critical to the deal community -- antitrust, financial reform, corporate accounting, tax policy, the impact of national security concerns on dealmaking and the effect consolidation has had on American society. Prior to joining The Deal, Bill was the Washington correspondent for Broadcasting & Cable, where he spent seven years reporting on the debate over media ownership, the FCC's crackdown on broadcast indecency and the rollout of digital television.

Recent Articles By The Author

Testy Relations with PBMs Coud Put Insurers on Hunt for Their Own Drug Buyers

Testy Relations with PBMs Coud Put Insurers on Hunt for Their Own Drug Buyers

More competition could help overcome the suspicion over drug prices that plagues the would-be business partners' dealings.

Behind the War Between Health Insurers and Pharmacy Benefit Managers

Behind the War Between Health Insurers and Pharmacy Benefit Managers

More competition could help overcome the suspicion over drug prices that plagues the would-be business partners' dealings.

Like Watching Paint Dry, Sherwin-Williams to Buy Valspar at Long Last

Like Watching Paint Dry, Sherwin-Williams to Buy Valspar at Long Last

FTC requires Sherwin Williams to sell Valspar's industrial wood coatings business to Axalta.

Revised Health Plan Offers Miniscule Change in Reducing Uninsured

Revised Health Plan Offers Miniscule Change in Reducing Uninsured

The latest CBO numbers are critical because Senate Republicans must decide whether to revise House bill or start from scratch.

Perrigo, Taro Show Perils of Failure to Branch in Branded Drugs

Perrigo, Taro Show Perils of Failure to Branch in Branded Drugs

The latest earnings from two of the largest generic drug makers show how important it is for generic firms to have their own stable of higher-margin branded products.